A Study of AK146D1 for Injection in the Treatment of Advanced Solid Tumors
NCT 06929663 Brief Summary This is an first-in-human, Phase I clinical study…
Read more arrow_forwardNCT 06929663 Brief Summary This is an first-in-human, Phase I clinical study…
Read more arrow_forwardNCT 06179160 Brief Summary This study is conducted to determine the safety…
Read more arrow_forwardNCT 06710847 Brief Summary Solid tumours are abnormal lumps of tissue that…
Read more arrow_forwardACTRN 12620000583943 Brief Summary The purpose of this study is to examine…
Read more arrow_forwardNCT 07110584 Brief Summary This study is designed to characterize the safety,…
Read more arrow_forwardACTRN 12625000191493 Brief Summary This study is evaluating the safety and properties…
Read more arrow_forwardACTRN 12623000959673 Brief Summary This study is evaluating the safety and properties…
Read more arrow_forwardACTRN 12621001537842 Brief Summary This trial aims to determine whether NOX66 (idronoxil)…
Read more arrow_forwardACTRN 12623001216606 Brief Summary The purpose of the study is to investigate…
Read more arrow_forwardNCT 06819735 Brief Summary This is a phase 1/2, dose-escalation and cohort-expansion…
Read more arrow_forward